Tang Carolyn C., General Counsel at Arcus Biosciences Inc. ($RCUS), sold common shares on the open market twice in the last 365 days for a total of $318,500. Her most recent $RCUS insider sale occurred on December 17, 2025. These transactions rank 7,421st among 11,678 individual insiders, below the average sale amount of $8.6 million across 6.4 transactions. Tang made no open market purchases of $RCUS stock in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 23, 2026 | Arcus Biosciences, Inc. | $RCUS | Tang Carolyn C. | General Counsel | A | Stock Option (right to buy) | 96000 | $0.00 | 96,000.0000 | 107,973,536 | 9999.99% | 0.09% |
| Jan. 23, 2026 | Arcus Biosciences, Inc. | $RCUS | Tang Carolyn C. | General Counsel | A | Common Stock | 24000 | $0.00 | 148,734.0000 | 107,973,536 | 19.24% | 0.02% |
| Dec. 17, 2025 | Arcus Biosciences, Inc. | $RCUS | Tang Carolyn C. | General Counsel | S | Common Stock | 6810 | $22.16 | 124,734.0000 | 107,973,536 | 5.18% | 0.01% |
| Dec. 16, 2025 | Arcus Biosciences, Inc. | $RCUS | Tang Carolyn C. | General Counsel | S | Common Stock | 7658 | $21.88 | 131,544.0000 | 107,973,536 | 5.50% | 0.01% |
| Jan. 23, 2025 | Arcus Biosciences, Inc. | $RCUS | Tang Carolyn C. | General Counsel | A | Common Stock | 37000 | $0.00 | 137,623.0000 | 0 | 36.77% | 0.00% |
| Jan. 23, 2025 | Arcus Biosciences, Inc. | $RCUS | Tang Carolyn C. | General Counsel | A | Stock Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 15, 2024 | Arcus Biosciences, Inc. | $RCUS | Tang Carolyn C. | General Counsel | F | Common Stock | 11339 | $16.08 | 100,623.0000 | 0 | 10.13% | 0.00% |
| June 15, 2024 | Arcus Biosciences, Inc. | $RCUS | Tang Carolyn C. | General Counsel | F | Common Stock | 4182 | $16.97 | 111,364.0000 | 0 | 3.62% | 0.00% |
| Jan. 23, 2024 | Arcus Biosciences, Inc. | $RCUS | Tang Carolyn C. | General Counsel | A | Stock Option (right to buy) | 108200 | $0.00 | 108,200.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | Arcus Biosciences, Inc. | $RCUS | Tang Carolyn C. | General Counsel | A | Common Stock | 26700 | $0.00 | 114,579.0000 | 0 | 30.38% | 0.00% |